Merck & Co. unveiled the much-anticipated first look at its PD-1xVEGF bispecific data. China's Zai Lab is looking to go ...

Patients’ confidence in their ability to find answers about health questions and make informed decisions has plummeted in the ...

With Regeneron poised to announce a drug pricing deal with the White House Thursday, all 17 companies targeted in a round of ...

Travis Smith was a very serious baby. Born completely unable to hear, his mother Sierra struggled to see his personality ...

While the scale of the currency headwinds in Roche’s first-quarter financial update caught many off guard, the company’s ...

In a brutal first quarter for Roche, key drugs in the company’s pharmaceutical division fall short of Wall Street ...

The FDA’s new practice of releasing redacted complete response letters (CRLs) in the name of “radical transparency” is ...

Nearly two-thirds of Americans are using artificial intelligence-based tools to seek medical information, while about ...

Normally on Big Pharma earnings calls, execs are eager to talk up their new launches and tout blockbuster expectations. | In ...

Evonik plans to spend roughly €80 million ($93.5 million) to upgrade the fermentation technology at its facility in Slovenská ...

As pharma giants slash headcounts and routinely strike billion-dol | Amid industry layoffs and M&A headlines, Big Pharma's ...

Samsung Bio is bringing its financial hot streak into 2026, with no signs of stopping—save for a potential worker strike ...